Abstract:The essential trace element iron is a major structural component required for the synthesis and function of hemoglobin and various enzymes, and is therefore involved in many key physiological processes, including oxygen transport, nucleic acid synthesis, gene expression, and immune regulation.Iron homeostasis is therefore essential to maintaining health.For example, iron deficiency leads to anemia, whereas iron overload can lead to the formation of free radicals, which cause lipid peroxidation, DNA damage, and changes in other bioactive molecules.Thus, iron overload has been implicated in a wide range of diseases, including hemochromatosis, diabetes, cardiovascular disease, neurodegeneration, and cancer.Systemically, iron homeostasis is tightly regulated by several processes, including iron absorption in the intestine, iron circulation in the blood, iron utilization in various tissues, iron storage in the liver, and iron recycling in splenic red pulp macrophages.In recent years, new genetic animal models and cutting-edge technologies have led to considerable progress regarding the molecular mechanisms that underlie iron metabolism.Ferroptosis, a recently identified iron-dependent form of cell death, has been implicated in several disease conditions, including acute kidney failure following ischemia/reperfusion, Huntington's disease, cancer, and neurodegeneration.Although no definitive biomarkers have been identified, lipid peroxidation, PTGS2 expression, and NADPH levels have been suggested as possible biomarkers of ferroptosis.Nevertheless, the regulatory mechanisms underlying ferroptosis are fairly complex and poorly understood.Recently, our understanding of the pathways that regulate hepcidin, the master regulator of iron homeostasis, has increased considerably.Hepcidin regulates systemic iron levels by facilitating degradation of the sole iron exporter, Ferroportin, thereby controlling the absorption, utilization, and storage of iron.Hepcidin also cooperatively regulates iron homeostasis in response to various stimuli; specifically, iron overload and inflammation upregulate hepcidin expression, whereas erythropoiesis and hypoxic stress downregulate hepcidin expression.In addition, several epigenetic processes regulate hepcidin expression, thereby regulating iron metabolism.New studies are continually revealing novel molecular mechanisms related to the complex networks that regulate hepcidin, providing exciting new possibilities for treating iron-related diseases.Iron-containing biological materials have also been studied for their clinical potential.For example, ferromagnetic nanoparticles, which are ferritin-or Fe 3 O 4 -containing biomacromolecules, have been applied in a wide variety of biomedical fields due to their superior magnetic properties and biocompatibility, making them ideal drug carriers.Importantly, nanoparticles readily penetrate the blood-brain barrier and enter the central nervous system, improving the bioavailability and therapeutic efficacy of drugs.Alternatively, an external magnetic field can be used to direct ferromagnetic nanoparticles to specific lesions.For example, a drug-containing transferrin nanoparticle complex could be used to targets specific tumor cells due to their increased expression of the transferrin receptor compared to healthy tissue.Superparamagnetic iron oxide nanoparticles may also be a promising tool for destroying cancer cells using a rapidly alternating external magnetic field.Thanks to their wide range of properties and features, ferromagnetic nanoparticles offer a wealth of promising biomedical applications.Here, we review the molecular mechanisms that regulate iron homeostasis, focusing on groundbreaking discoveries in hepcidin regulation and recent progress regarding biomedical applications for ferromagnetic nanoparticles.iron homeostasis, iron-deficient anemia, iron overload,

Minimizing higher-order aggregation maximizes iron mobilization by small molecules

Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals

Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency

Melanin Nanoparticles As an Endogenous Agent for Efficient Iron Overload Therapy

Iron for proliferation of cell lines and hematopoietic progenitors: Nailing down the intracellular functional iron concentration

A nanoparticulate ferritin-core mimetic is well taken up by HuTu 80 duodenal cells and its absorption in mice is regulated by body iron

Transferrin-inspired iron delivery across the cell membrane using [(L2Fe)2(μ-O)] (L = chlorquinaldol) to harness anticancer activity of ferroptosis

ATH434, a promising iron-targeting compound for treating iron regulation disorders

In vitro reconstitution, functional dissection, and mutational analysis of metal ion transport by mitoferrin-1

Heme Scavenging with Apohemoglobin-Haptoglobin Complex in Beta Thalassemia Intermedia Improves Anemia and Iron Indices: A Novel Therapeutic Approach

New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis

Formation mechanism and biological activity of novel thiolated human-like collagen iron complex

Oral Non-absorbable Polymer-Deferoxamine Conjugates for Reducing Dietary Iron Absorption

Solid-Phase Synthesis and In-Silico Analysis of Iron-Binding Catecholato Chelators

Advances in Iron Homeostasis and Ferromagnetic Nanoparticles

Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia

Disposal of iron by a mutant form of lipocalin 2

Feraheme® suppresses immune function of human T lymphocytes through mitochondrial damage and mitoROS production

Molecular Mechanisms of Iron Transport and Homeostasis Regulated by Antarctic Krill-Derived Heptapeptide-Iron Complex

Iron Cycle Tuned by Outer-Membrane Cytochromes of Dissimilatory Metal-Reducing Bacteria: Interfacial Dynamics and Mechanisms in Vitro.

5-Hydroxypyran-4-one Derivatives As Potential Therapeutic Iron-Chelating Agents